After he was diagnosed with chondrosarcoma, Mike Cleek opted for a complex hemipelvectomy. Jesse Roberts, MD, relied on a 3D ...
Headlines suggest popular diabetes and weight-loss drugs prevent cancer, but epidemiologists warn that early observational ...
The headlines were everywhere – from NPR and The Washington Post to Substack and heated exchanges on social media – all ...
ROBINSON, Texas (KWTX) — Brandon Crouch was running out of time. The 54-year-old Robinson, Texas, man and owner of Ironhorse Roofing had been on dialysis for nearly three and a half years after Type 1 ...
SurvivorNet on MSN
New approval means more bladder cancer patients can access powerful immunotherapy combination: What to know about Keytruda + Padcev
A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, ...
The devastating diagnosis also turned out to be his first productive step toward negotiating a disease he had long feared would take his life.
From vaccines to AI-powered healthcare, America's medical breakthroughs over 250 years have transformed disease prevention, diagnosis, treatment, and survival worldwide. , Health, Times Now ...
Joe Gillette's morning commute hadn't changed in years — until the three-lane highway became four lanes one day. He realized he was seeing double out of one eye. He thought it might be a side effect ...
Photographer Peter Grant was diagnosed with stage 4 pancreatic cancer at age 65, a diagnosis that took him by complete surprise, considering his other superb health at the time He was given a ...
Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) treatment space, notching a Keytruda combination nod that stands to pad the ...
People with advanced heart, kidney, and metabolic disease may face a higher risk of developing cancer, according to new research published in Circulation: Population Health and Outcomes. The ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had a similar risk for kidney cancer if they used a GLP-1 compared with an SGLT2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results